CHEM INTERNATIONAL INC
DEF 14A, 1997-10-28
PHARMACEUTICAL PREPARATIONS
Previous: MAR VENTURES INC, 8-K, 1997-10-28
Next: CAPITAL TITLE GROUP INC, 10QSB, 1997-10-28






                           CHEM INTERNATIONAL, INC.



                                                               November 5, 1997

To Our Stockholders:

       On behalf of the Board of Directors,  it is our pleasure to invite you to
attend the Annual  Meeting of  Stockholders  of Chem  International,  Inc.  (the
"Company"),  which will be held at 9:00 a.m.  local time on November 26, 1997 at
the  Headquarters  Plaza Hotel, 3  Headquarters  Plaza,  Morristown,  New Jersey
07960.

      At the Annual Meeting, you will be asked to vote on proposals:

      1. to elect two class I Directors for a three year term;

      2.    to ratify the appointment of independent auditors of the Company for
            the 1998 fiscal year; and

      3. to act upon  such  other  business  as may  properly  come  before  the
Meeting:

      It is important  that your shares be  represented  at the Annual  Meeting,
whether or not you are able to attend. Accordingly,  you are urged to sign, date
and mail the enclosed proxy  promptly.  If you later decide to attend the Annual
Meeting, you may revoke your proxy and vote your shares in person.


                                                               Sincerely,




                                                                 E. Gerald Kay
                                                                   President and
                                                         Chief Executive Officer


<PAGE>



                           CHEM INTERNATIONAL, INC.
                                 201 Route 22
                          Hillside, New Jersey 07205

                   NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
                                                                                
                        BE HELD ON NOVEMBER 26, 1997

                            TO THE STOCKHOLDERS OF
                           CHEM INTERNATIONAL, INC.:

    NOTICE  IS  HEREBY  GIVEN  that  an  Annual  Meeting  of  Stockholders  (the
"Meeting") of Chem International,  Inc., a Delaware corporation ( "Chem"),  will
be held on November  26, 1997,  at 9:00 a.m.,  local time,  in the  Headquarters
Plaza Hotel, 3 Headquarters Plaza, Morristown,  New Jersey 07960 for the purpose
of considering and acting upon the following:

      1.  The election of two Directors to Chem's Board of Directors to serve a
           three-year term  as  Class I Directors;

      2.   Ratification  of the  appointment of Moore  Stephens,  P.C. as Chem's
           independent accountants for the fiscal year ending June 30, 1998;

      3.         The  transaction  of such other  business as may properly  come
                 before the Meeting or any adjournment thereof.

     THE BOARD OF DIRECTORS UNANIMOUSLY  RECOMMENDS THAT THE
STOCKHOLDERS VOTE "FOR"  PROPOSALS NO. 1 AND NO. 2 TO BE PRESENTED
TO CHEM  STOCKHOLDERS AT THE  MEETING.

                                             By Order of the Board of Directors.



                                                             Eleanor DiMartino
                                                                Secretary

Hillside, New Jersey
November 5, 1997

      It is important that your shares be represented at this meeting in order
 that a quorum may be assured.WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, YOU
ARE URGED TO DATE,  SIGN AND  PROMPTLY  MAIL THE  ENCLOSED  CARD IN THE  POSTAGE
PREPAID  ENVELOPE  PROVIDED AND TO DO SO IN ADEQUATE TIME FOR YOUR DIRECTIONS TO
BE RECEIVED AND TABULATED PRIOR TO THE SCHEDULED MEETING.


<PAGE>



                           CHEM INTERNATIONAL, INC.
                                 201 Route 22
                          Hillside, New Jersey 07205

                                PROXY STATEMENT
                      1997 ANNUAL MEETING OF STOCKHOLDERS

                        To be held on November 26, 1997


                              GENERAL INFORMATION

      This Proxy Statement is furnished in connection  with the  solicitation of
proxies on behalf of the Board of Directors (the "Board") of Chem International,
Inc.,  ("Chem" or the  "Company"),  a Delaware  corporation,  to be voted at the
Annual Meeting of Stockholders of the Company (the "Annual  Meeting") to be held
at the Headquarters Plaza Hotel, 3 Headquarters  Plaza,  Morristown , New Jersey
07960 on November 26, 1997, at 9:00 a.m. local time, or at any  postponement  or
adjournment thereof. This Proxy Statement,  the Notice of Annual Meeting and the
accompanying  form of proxy are first being mailed to  stockholders  on or about
November 5, 1997.

    Only holders of record of the Company's  common  stock,  par value $.002 per
share  ("Common  Stock"),  at the close of  business  on October  28,  1997 (the
"Record  Date"),  are  entitled  to vote on the matters to be  presented  at the
Annual  Meeting.  The number of shares of Common Stock  outstanding on such date
and entitled to vote was 4,335,000.  Holders of Common Stock are entitled to one
vote on each matter to be voted upon by the  stockholders  at the Annual Meeting
for each share held.

    At the Annual Meeting,  stockholders will be asked to consider and vote upon
(1) the election of two  directors to Chem's Board of Directors  each to serve a
three-year term as Class I Directors and (2) the ratification of the appointment
of Moore  Stephens,  P.C.  as Chem's  independent  auditors  for the fiscal year
ending  June 30,  1998 ( the"  Independent  Auditors  Proposal").  At the Annual
Meeting  stockholders may also be asked to consider and take action with respect
to such other matters as may properly come before the Annual Meeting.


                         QUORUM AND VOTE REQUIREMENTS


   The  presence,  in person or by proxy,  of holders of record of a majority of
the  shares of Common  Stock  issued and  outstanding  and  entitled  to vote is
required  for a quorum to  transact  business  at the Annual  Meeting,  but if a
quorum should not be present,  the Annual  Meeting may be adjourned from time to
time until a quorum is obtained.  Directors  are elected by a plurality of votes
cast. The Independent  Auditors  Proposal and all other matters to properly come
before the Meeting will be determined by the affirmative  vote of the holders of
a majority of the shares of


<PAGE>



Common Stock present,  in person or by proxy, and entitled to vote at the Annual
Meeting.  Broker "non-votes" (i.e.  proxies from brokers or nominees  indicating
that such persons have not received  instructions  from the beneficial  owner or
other  persons  entitled to vote shares as to a matter with respect to which the
brokers  or  nominees  do not have  discretionary  power to vote) and shares for
which duly executed proxies have been received but with respect to which holders
of shares have  abstained from voting will be treated as present for purposes of
determining  the  presence of a quorum at the Annual  Meeting.  Abstentions  and
broker  non-votes  have no impact on the election of Directors  except to reduce
the number of votes for the  nominees.  Broker "non- votes" are only counted for
purposes of determining whether a quorum is present and, therefore,  will not be
included  in vote  totals and will have no effect on the outcome of the votes on
all other proposals to be acted upon at the Annual Meeting.  Abstentions will be
counted as present and entitled to vote,  and will have the effect of a negative
vote with respect to all other proposals to be acted upon at the Annual Meeting.

                          SOLICITATION AND REVOCATION

   PROXIES IN THE FORM ENCLOSED ARE BEING SOLICITED BY, AND  ON BEHALF
OF, THE BOARD. THE PERSONS NAMED IN THE ACCOMPANYING FORM OF PROXY
HAVE BEEN DESIGNATED AS PROXIES BY THE BOARD.

    All Common Stock represented by properly executed proxies which are returned
and not  revoked  prior  to the  time of the  Annual  Meeting  will be  voted in
accordance with the instructions,  if any, given thereon. If no instructions are
provided in an executed proxy, it will be voted (1) in favor of the nominees for
election as directors named below and (2) FOR the Independent Auditors Proposal,
and in accordance  with the  proxyholder's  discretion as to any other  business
raised at the Annual Meeting. Any stockholder who executes a proxy may revoke it
at any time before it is voted by delivering to the Company a written  statement
revoking  such proxy,  by executing  and  delivering a later dated proxy,  or by
voting in person at the Annual  Meeting.  Attendance at the Annual  Meeting by a
stockholder  who has executed and  delivered a proxy to the Company shall not in
and of itself constitute a revocation of such proxy.

   The Company will bear its own cost of the  solicitation  of proxies.  Proxies
will  be  solicited  initially  by  mail.  Further  solicitation  may be made by
directors,  officers and  employees of the Company  personally,  by telephone or
otherwise,  but any such person will not be  specifically  compensated  for such
services.  The Company also  intends to make,  through  banks,  brokers or other
persons,  a solicitation  of proxies of beneficial  holders of the Common Stock.
Upon request,  the Company will reimburse  brokers,  dealers,  banks and similar
entities  acting as nominees  for  reasonable  expenses  incurred in  forwarding
copies of the proxy  materials  relating to the Annual Meeting to the beneficial
owners of Common Stock which such persons hold of record.








<PAGE>



                     PROPOSAL NO. 1-ELECTION OF DIRECTORS


      The  following  table sets forth certain  information  with respect to the
members  of Chem's  Board of  Directors,  including  the two  incumbent  Class I
Directors  (Mr.  Kay and Ms. Riva Kay) who have been  nominated  by the Board of
Directors for re-election as Class I Directors at the Annual Meeting.
      The Board of Directors  knows of no reason why any of its nominees will be
unable or will  refuse to accept  election.  If any  nominee  becomes  unable or
refuses to accept election, the Board of Directors will either reduce the number
of  directors  to be elected or select a  substitute  nominee.  If a  substitute
nominee is selected, proxies will be voted in favor of such nominee.
      The class I Directors shall be elected by a plurality of the votes cast.


<TABLE>
                                                                                                              Class of    Director
Name, Principal Occupation                                                                       Age          Directors    Since
<S>                                                                                           <C>          <C>               <C>  

E. Gerald Kay                                                                                  61            Class I           1980
  Served as Chairman of the Board and President
  of the Company since 1980. Mr. Kay is also a
  director of  Trans Global Services, Inc . a publicly
  traded temporary personnel company and International Magnetic
  Imaging, Inc. a medical diagnostic imaging company.
Riva Kay                                                                                        30            Class I           1991
  Served as Vice President  and a director of the
  Company since May 1991. Ms. Kay is the daughter
   of E. Gerald Kay and the sister of  Christina Kay.
Christina Kay                                                                                    27           Class  II         1994
  Served as Vice President and a director of the Company
   since December 1994. From March 1994 until November
  1994 she was an administrative assistant at Squadron,
  Ellenoff, Plesant and Sorkin,  a New York City law firm.
  Prior to her employment at that firm she was associated
   with Meridan Publishing. Ms. Kay is the daughter of
  E. Gerald Kay and the sister of Riva Kay.
Robert Canarick                                                                                  47           Class II        1994
  Served as a director of the Company since December 1994.
  Since  January  1995,  he has  served as Vice  President  and Chief  Financial
  Officer of UVW Elizabeth Group, LLC an all lines independent insurance agency.
  From 1989 to December  1994,  Mr.  Canarick  was  President  of The  Elizabeth
  Agency,  Inc., a predecessor of his present Company.  Mr. Canarick is a member
  of the Audit Committee.






Leonard Stowe                                                                                     59           Class III     1994
  Served as a director of the Company since 1994. Since
  April 1997, he has served as Vice President of Nations Credit
  Commercial Funding, Inc. From April 1996 until April 1997, he
  served as Vice President of CIT Credit Finance. From 1970
  to April 1996, Mr. Stowe was employed by Gibraltar Corp.
  of America, a subsidiary of UJB Financial Corp. Mr. Stowe
  is a member of the Audit Committee.

Recommendation and Vote

</TABLE>

       The Board unanimously  recommends a vote FOR the election of the Nominees
to the Board.


        SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

      The  following  table sets forth,  as of October 1, 1997,  the  beneficial
ownership of Common Stock of the Company by each executive officer and director,
all executive  officers and  directors as a group,  and each person known to the
Company to own beneficially or five percent or more of the outstanding shares of
the Company.
<TABLE>



<S>                                 <C>                                   <C> 
                                     Shares
Officers, Directors and                       Beneficially                      Percent of Shares
Principal Stockholders                         Owned (1)                       Beneficially Owned

E. Gerald Kay                                    1,894,678(2)                           42.7%
Riva Kay                                           252,661(3)                            5.7%
Christina Kay                                       252,661(4)                           5.7%
Eric Friedman                                       100,000(5)                           2.3%
Ronald Smalley                                       25,000(6)                             *
Robert Canarick                                      25,000(7)                             *
Leonard Stowe                                        25,000(8)                             *


All directors,
executive officers
as a group (7 persons)                        2,575,000                                 53.5%
- -----------------
*Less than 1%

(1)   Unless otherwise indicated by footnote, the named persons have sole voting
      and   investment   power  with  respect  to  the  share  of  Common  Stock
      beneficially owned.
(2) Includes 100,000 shares subject to presently exercisable stock options.

</TABLE>

<PAGE>



(3) Includes 100,000 shares subject to presently  exercisable  stock options (4)
Includes  100,000 shares  subject to presently  exercisable  stock options.  (5)
Includes  100,000  shares  subject to presently  exercisable  stock  options (6)
Includes  25,000 shares  subject to presently  exercisable  stock  options.  (7)
Includes  25,000 shares  subject to presently  exercisable  stock  options.  (8)
Includes 25,000 shares subject to presently exercisable stock options




                                   DIRECTORS


     The Board of Directors held ten meetings  during the fiscal year ended June
30, 1997, and all directors attended at least 75% of those meetings.
     No  compensation  was paid to any director for his services to the Board of
Directors or any committee..
     The  only  standing  committee  of the  Board  of  Directors  is the  Audit
Committee,  whose members are Messrs.  Canarick and Stowe.  The Audit  Committee
periodically  consults  with the Company's  management  and  independent  public
accountants on financial  matters,  including the Company's  internal  financial
controls and  procedures.  The Audit Committee meet once in Fiscal 1997, and all
members attended the meeting. The Company's stock option plan is administered by
a committee composed of Messrs. Canarick and Stowe.



                              EXECUTIVE OFFICERS

     The following individuals are executive officers of the Company but are not
Directors or Nominees for Director:

    Eric  Friedman,  age 49, has been the Vice  President  and  Treasurer of the
Company  since June 1996.  From June 1978  though May 1996,  he was a partner in
Shachat  and  Simson,  a  certified  public  accounting  firm that  audited  the
Company's financial statements from June 1976 until June 1995. Mr. Friedman is a
director  of All  Communications  Corporation,  Inc.,  a publicly  traded  video
conferencing and communications company.

   Ronald  Smalley , age 52, has been Vice  President-Technology  of the Company
since  April  1993.  From 1991 to March  1993,  Mr.  Smalley  was Manager of OTC
Development at SmithKline Beecham, in charge of product development.







<PAGE>



            SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

     Based on a review of Forms 3,4 and 5 submitted  to the  Company  during and
with respect to Fiscal 1997, all statements of beneficial  ownership required to
be filed with the  Securities  and Exchange  Commission  (the"Commission")  were
timely filed.




                            EXECUTIVE COMPENSATION


      The following table shows,  for the fiscal years ended June 30, 1997, 1996
and 1995, certain compensation information as to the Chief Executive Officer and
each of the most highly compensated executive officers of the Company who served
as  executive  officers  during the fiscal  year ended June 30, 1997 (the "Named
Executive Officers").

<TABLE>

                  SUMMARY COMPENSATION TABLE

                                                         Annual Compensation           Long Term Compensation


                                                                               Securities
          Name and                                                            underlying         All Other
          principal Position           Year        Salary         Bonus       Stock Options    Compensation
          ------------------------    -----    -----------     ----------    -------------   ------------
<S>                                 <C>         <C>          <C>                <C>                 <C>  

E. Gerald Kay                         1997      $ 150,000     $     -                 100,000       $  11,454(5)
Chairman of the Board,                1996         134,850            -              -                 13,846(2)(5)
President and Chief                   1995         230,550       250,000             -                 40,885(2)(5)
Executive Officer

Eric Friedman
Chief Financial Officer and          1997         215,000       104,135           100,000               6,059(3)(5)
Vice President(1)                    1996           16,538             -                           -                         -

Ronald  Smalley                       1997         100,000           2,688            25,000             5,553(4)(5)
Vice President                        1996         100,000           4,419               -               5,478(4)(5)
                                       1995        100,000              -                    -          11,481(4)(5)
</TABLE>

(1)   The amount shown for 1996 reflects  less than a full year of  compensation
      for Mr. Friedman who was employed by the Company from June 1, 1996.
(2)   Includes the Company's portion of premiums amounting to $5,947 and $16,147
      during the fiscal years ended June 30, 1996 and 1995 , respectively,  on a
      split dollar life  insurance  arrangement  on Mr. Kay's life.  The Company
      also provides Mr. Kay with the use of a Company car.


<PAGE>



(3)  Includes  an  automobile  allowance  of $6,000  in 1997.  (4)  Includes  an
automobile  allowance of $3,600 in 1997, 1996 and 1995. (5) The disclosed amount
includes the Company's matching contributions under the Company's
       401-K  plan and,  for 1995 only,  contributions  to the  defined  benefit
pension plan.


                            Employment Agreements

    Effective  July 1, 1996  (January  1, 1996 as to Mr.  Smalley),  the Company
entered into employment agreements with E. Gerald Kay, President, Eric Friedman,
Vice President and Ronald Smalley, Vice President of the Company. The employment
contracts,  each of which  expires June 30, 1999 provide for such  executives to
receive annual base salaries as follows:  E. Gerald Kay $150,000 for fiscal year
ending June 30,  1997,  and  $250,000  for fiscal years ending June 30, 1998 and
1999; Eric Friedman, $215,000 and Ronald Smalley $100,000.

    The contracts  provide that the Company and the employees shall negotiate an
increase in such employees' salary for each succeeding  contract year (July 1 of
each  year) and upon  failure  of the  parties  to agree on such  increase,  the
employees'  base  salary  shall  be  increased  by a  percentage  equal  to  the
percentage  increase in the consumer price index for all urban consumers,  North
Eastern  area,  for the preceding  calendar  year.  Each of these  employees has
agreed to devote  his full time and best  efforts to  fulfill  their  duties and
responsibilities to the Company. Each of them will be entitled to participate in
employee  benefit plans and to receive  stock options under the Company's  stock
option plan on the basis  commensurate with their salary and the amount of stock
options granted to other management employees.

   The Company has the right to terminate the employment  agreements for "cause"
as defined in the  employment  agreements  and the Company also has the right to
terminate  an employee  without  cause,  upon not less than  thirty  days' prior
written  notice,  provided  that  the  employee  shall be  entitled  to the full
compensation  due for the  remainder of the  employment  term.  The employee may
terminate the agreement at any time upon thirty days' prior written  notice.  In
such event the employee shall only be entitled to the  compensation  due through
the date of  termination.  Such  employees  have also agreed not to disclose any
confidential  information  of the  Company  during  the  term of  employment  or
thereafter.  These  employees have agreed not to compete with the Company during
the  term  of  employment  and  for a  period  of one  year  after  the  date of
termination of employment  with the Company in the event that such employment is
terminated for cause or the employee  voluntarily leaves prior to the end of the
employment term.







                                 OPTION GRANTS
                  DURING THE FISCAL YEAR ENDED JUNE 30, 1997


<PAGE>


<TABLE>


       The following table sets forth individual grants of stock options by Chem
pursuant  to the  Chem  International,  Inc.  Stock  Option  Plan  to the  Named
Executive Officers during the fiscal year ended June 30, 1997.

                                                                 % of Total
                                                                  Granted to
                                Securities Options    Employees in   Exercise      Expiration
Name                            Granted (#)(1)      Fiscal  Year      Price (2)          Date
- -----------------          -------------------    ---------------  ------------  ------------
<S>                           <C>                  <C>              <C>           <C>          

E. Gerald Kay                  74,026                 12.4%           $3.50        October 16, 2006
E. Gerald Kay                  25,974                  4.3%           $3.85        October 16, 2001
Eric Friedman                 100,000                  6.7%           $3.50        October 16, 2006
Ronald Smalley                25,000                   4.2%           $3.50        October 16, 2006

(1)   The date of grant for these  options was October 16,  1996,  which  became
      exercisable on October 16, 1997.
(2)   The  exercise  price of the options is equal to the fair  market  value of
      shares of Common Stock of Chem on the date of grant of the options  except
      for the  25,974 of  incentive  stock  options  granted to Mr. Kay which is
      equal to 110% of the fair market value on the date of grant.


</TABLE>

        AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR
END OPTION VALUES


      The  following  table sets  forth  information  with  respect to the Named
Executive  Officers  concerning  the exercise of options  during the last fiscal
year and  unexercised  options held at the end of the fiscal year ended June 30,
1997:

<TABLE>                                                 
                                                         NUMBER OF
                                                        SECURITIES           VALUE OF
                                                        UNDERLYING          UNEXERCISED
                                                        UNEXERCISED         IN-THE-MONEY
                                                        OPTIONS AT             OPTIONS AT
                              SHARES                    FISCAL YEAR        FISCAL YEAR END
                            ACQUIRED           VALUE       END(#)              ($)
                           ON EXERCISE       REALIZED    EXERCISABLE/       EXERCISABLE/
 NAME                     (#)                        ($)UNEXERCISABLE      UNEXERCISABLE
      -----------------------------------------------------------------------------------------------------------------
<S>                       <C>            <C>                 <C>               <C> 

E. Gerald Kay               --            --                   0/ 100,000        0/ 0
Eric Friedman               --            --                   0/ 100,000        0/ 0
Ronald Smalley             --             --                   0/  25,000        0/ 0

</TABLE>

<PAGE>







                    CERTAIN RELATIONSHIPS AND TRANSACTIONS

     The Company leases  manufacturing  and office  facilities from Gerob Realty
Partnership  whose  partners  are E. Gerald Kay,  Riva Kay and  Christina  Kay (
stockholders and directors of the Company).  The lease which expires on December
31,  1997  provides  for an annual  rental of $60,000  plus  payment of all real
estate taxes.
     Other  warehouse  and office  facilities  are leased  from  Vitamin  Realty
Associates, L.L.C., a limited liability company, which is 90% owned by E. Gerald
Kay, Riva Kay and Christina Kay (all  stockholders and directors of the Company)
and 10% owned by Eric Friedman, the Company's Chief Financial Officer. The lease
was  effective on January 10, 1997 and provides  for minimum  annual  rentals of
$346,000  through  January 10,  2002 plus  increases  in real  estate  taxes and
building operating  expenses.  At its option, the Company has the right to renew
the lease for an additional five year period.

    On  September  10, 1982,  the Company  issued a note payable to Gerob Realty
Partnership,  which note  currently  has  principal  remaining  in the amount of
$276,444. The note was a fifteen year non-interest bearing note due on September
10, 1997. The note has been renewed for a new five year term.

                              CHANGE OF AUDITORS

      Effective  December 4, 1996,  the Company  dismissed its prior  certifying
accountants,  Cornick, Garber & Sandler,  LLP("Cornick") and retained as its new
certifying  accountants,  Moore Stephens, P.C. Cornick's report on the Company's
financial  statements  during the most recent  fiscal year  contained no adverse
opinion or a disclaimer  of opinion,  and was not  qualified as to  uncertainty,
audit scope or accounting  principles.  There were no disagreements with Cornick
on any  matter  of  accounting  principles  or  practices,  financial  statement
disclosure,  or auditing scope or procedure.  The decision to change accountants
was approved by the Company's Board of Directors.

                                        PROPOSAL NO. 2-RATIFICATION OF
                    THE APPOINTMENT OF INDEPENDENT AUDITORS


    The Board of Directors  of Chem has  appointed  the firm of Moore  Stephens,
P.C.,  independent auditors,  to audit the consolidated  financial statements of
Chem  International,  Inc. and its  subsidiaries for the fiscal year ending June
30,1998, subject to ratification by the Chem Stockholders.

   A member of Moore Stephens, P.C. is expected to be present at the Annual
 Meeting and to be

<PAGE>



provided with an opportunity to make a statement if such member desires to do so
and to be available to respond to appropriate questions from shareholders

Recommendation and Vote

       Approval of the Independent  Auditors  Proposal  requires the affirmative
vote of a majority of the shares of Common Stock present, in person or by proxy,
at the Annual Meeting.


     The Board unanimously recommends a vote FOR the approval of the Independent
Auditors Proposal.




                 DATE FOR SUBMISSION OF STOCKHOLDER PROPOSALS

       Stockholder  proposals to be included in the  Company's  proxy  statement
with respect to the 1998 Annual Meeting of Stockholders  must be received by the
Company its  executive  offices  located at 201 Route 22,  Hillside,  New Jersey
07205 no later than July 16, 1998.


                         OTHER BUSINESS OF THE MEETING

     The Company is not aware of any  matters to come before the Annual  Meeting
other than those stated in this Proxy Statement. However, inasmuch as matters of
which  management  of the  Company  is not now aware may come  before the Annual
Meeting or any  adjournment,  the proxies  confer  discretionary  authority with
respect to acting thereon, and the persons named in such proxies intend to vote,
act and consent in accordance with their discretion with respect thereto.


                            ADDITIONAL INFORMATION


     COPIES OF THE  COMPANY'S  ANNUAL  REPORT ON FORM  10-KSB FOR THE YEAR ENDED
JUNE 30, 1997 MAY BE OBTAINED  WITHOUT  CHARGE BY ANY  STOCKHOLDER  TO WHOM THIS
PROXY STATEMENT IS SENT,  UPON WRITTEN  REQUEST TO THE CHIEF FINANCIAL  OFFICER,
CHEM INTERNATIONAL, INC., 201 ROUTE 22, HILLSIDE, NEW JERSEY 07205.


                                         By Order of the Board of Directors





<PAGE>

                                                    E. Gerald Kay
                                                  Chairman, President and
                                                  Chief Executive Officer

November 5, 1997



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission